New therapy for atherosclerosis developed by Ben-Gurion University

(American Associates, Ben-Gurion University of the Negev) 'Our E-selectin-targeting polymer reduces existing plaque and prevents further plaque progression and inflammation, preventing arterial thrombosis, ischemia, myocardial infarction, and stroke,' says Prof. Ayelet David of the BGU Department of Clinical Biochemistry and Pharmacology.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news